カテゴリー： 世界, 医療/バイオ, Market Monitor Global

フォスタマチニブ錠剤のグローバル市場展望 2023年-2029年：100mg、150mg

【英語タイトル】Fostamatinib Tablets Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23DC14328）・商品コード：MMG23DC14328
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年12月（※2025年版があります。お問い合わせください。）
・ページ数：76
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のフォスタマチニブ錠剤市場規模と予測を収録しています。・世界のフォスタマチニブ錠剤市場：売上、2018年-2023年、2024年-2029年
・世界のフォスタマチニブ錠剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のフォスタマチニブ錠剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「100mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

フォスタマチニブ錠剤のグローバル主要企業は、Rigel Pharmaceuticals、 Kissei Pharmaceutical、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZenecaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、フォスタマチニブ錠剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のフォスタマチニブ錠剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のフォスタマチニブ錠剤市場：タイプ別市場シェア、2022年
・100mg、150mg

世界のフォスタマチニブ錠剤市場：用途別、2018年-2023年、2024年-2029年
世界のフォスタマチニブ錠剤市場：用途別市場シェア、2022年
・慢性免疫性血小板減少症（ITP）、ヴァルデンシュトレームマクログロブリン血症、自己免疫性溶血性貧血、その他

世界のフォスタマチニブ錠剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のフォスタマチニブ錠剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるフォスタマチニブ錠剤のグローバル売上、2018年-2023年
・主要企業におけるフォスタマチニブ錠剤のグローバル売上シェア、2022年
・主要企業におけるフォスタマチニブ錠剤のグローバル販売量、2018年-2023年
・主要企業におけるフォスタマチニブ錠剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Rigel Pharmaceuticals、 Kissei Pharmaceutical、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZeneca

*************************************************************

・調査・分析レポートの概要
フォスタマチニブ錠剤市場の定義
市場セグメント
世界のフォスタマチニブ錠剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のフォスタマチニブ錠剤市場規模
世界のフォスタマチニブ錠剤市場規模：2022年 VS 2029年
世界のフォスタマチニブ錠剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのフォスタマチニブ錠剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のフォスタマチニブ錠剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：100mg、150mg
フォスタマチニブ錠剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：慢性免疫性血小板減少症（ITP）、ヴァルデンシュトレームマクログロブリン血症、自己免疫性溶血性貧血、その他
フォスタマチニブ錠剤の用途別グローバル売上・予測

・地域別市場分析
地域別フォスタマチニブ錠剤市場規模 2022年と2029年
地域別フォスタマチニブ錠剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Rigel Pharmaceuticals、 Kissei Pharmaceutical、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZeneca
...

This research report provides a comprehensive analysis of the Fostamatinib Tablets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fostamatinib Tablets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fostamatinib Tablets, challenges faced by the industry, and potential opportunities for market players.
The global Fostamatinib Tablets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fostamatinib Tablets market presents opportunities for various stakeholders, including Chronic Immune Thrombocytopenia (ITP), Waldenström’s Macroglobulinemia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fostamatinib Tablets market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fostamatinib Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Fostamatinib Tablets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fostamatinib Tablets market.
Market Overview: The report provides a comprehensive overview of the Fostamatinib Tablets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 100 mg, 150 mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fostamatinib Tablets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fostamatinib Tablets market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fostamatinib Tablets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fostamatinib Tablets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fostamatinib Tablets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fostamatinib Tablets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fostamatinib Tablets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fostamatinib Tablets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fostamatinib Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
100 mg
150 mg
Market segment by Application
Chronic Immune Thrombocytopenia (ITP)
Waldenström’s Macroglobulinemia
Autoimmune Haemolytic Anaemia
Other
Global Fostamatinib Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Rigel Pharmaceuticals
Kissei Pharmaceutical
Grifols
JW Pharmaceutical Corporation
Medison Pharma Canada
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fostamatinib Tablets, market overview.
Chapter 2: Global Fostamatinib Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Fostamatinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fostamatinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fostamatinib Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Fostamatinib Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fostamatinib Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fostamatinib Tablets Overall Market Size
2.1 Global Fostamatinib Tablets Market Size: 2022 VS 2029
2.2 Global Fostamatinib Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fostamatinib Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Fostamatinib Tablets Players in Global Market
3.2 Top Global Fostamatinib Tablets Companies Ranked by Revenue
3.3 Global Fostamatinib Tablets Revenue by Companies
3.4 Global Fostamatinib Tablets Sales by Companies
3.5 Global Fostamatinib Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fostamatinib Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fostamatinib Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fostamatinib Tablets Players in Global Market
3.8.1 List of Global Tier 1 Fostamatinib Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Fostamatinib Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fostamatinib Tablets Market Size Markets, 2022 & 2029
4.1.2 100 mg
4.1.3 150 mg
4.2 By Type – Global Fostamatinib Tablets Revenue & Forecasts
4.2.1 By Type – Global Fostamatinib Tablets Revenue, 2018-2023
4.2.2 By Type – Global Fostamatinib Tablets Revenue, 2024-2029
4.2.3 By Type – Global Fostamatinib Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Fostamatinib Tablets Sales & Forecasts
4.3.1 By Type – Global Fostamatinib Tablets Sales, 2018-2023
4.3.2 By Type – Global Fostamatinib Tablets Sales, 2024-2029
4.3.3 By Type – Global Fostamatinib Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Fostamatinib Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fostamatinib Tablets Market Size, 2022 & 2029
5.1.2 Chronic Immune Thrombocytopenia (ITP)
5.1.3 Waldenström’s Macroglobulinemia
5.1.4 Autoimmune Haemolytic Anaemia
5.1.5 Other
5.2 By Application – Global Fostamatinib Tablets Revenue & Forecasts
5.2.1 By Application – Global Fostamatinib Tablets Revenue, 2018-2023
5.2.2 By Application – Global Fostamatinib Tablets Revenue, 2024-2029
5.2.3 By Application – Global Fostamatinib Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Fostamatinib Tablets Sales & Forecasts
5.3.1 By Application – Global Fostamatinib Tablets Sales, 2018-2023
5.3.2 By Application – Global Fostamatinib Tablets Sales, 2024-2029
5.3.3 By Application – Global Fostamatinib Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Fostamatinib Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fostamatinib Tablets Market Size, 2022 & 2029
6.2 By Region – Global Fostamatinib Tablets Revenue & Forecasts
6.2.1 By Region – Global Fostamatinib Tablets Revenue, 2018-2023
6.2.2 By Region – Global Fostamatinib Tablets Revenue, 2024-2029
6.2.3 By Region – Global Fostamatinib Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Fostamatinib Tablets Sales & Forecasts
6.3.1 By Region – Global Fostamatinib Tablets Sales, 2018-2023
6.3.2 By Region – Global Fostamatinib Tablets Sales, 2024-2029
6.3.3 By Region – Global Fostamatinib Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fostamatinib Tablets Revenue, 2018-2029
6.4.2 By Country – North America Fostamatinib Tablets Sales, 2018-2029
6.4.3 US Fostamatinib Tablets Market Size, 2018-2029
6.4.4 Canada Fostamatinib Tablets Market Size, 2018-2029
6.4.5 Mexico Fostamatinib Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fostamatinib Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Fostamatinib Tablets Sales, 2018-2029
6.5.3 Germany Fostamatinib Tablets Market Size, 2018-2029
6.5.4 France Fostamatinib Tablets Market Size, 2018-2029
6.5.5 U.K. Fostamatinib Tablets Market Size, 2018-2029
6.5.6 Italy Fostamatinib Tablets Market Size, 2018-2029
6.5.7 Russia Fostamatinib Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Fostamatinib Tablets Market Size, 2018-2029
6.5.9 Benelux Fostamatinib Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fostamatinib Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Fostamatinib Tablets Sales, 2018-2029
6.6.3 China Fostamatinib Tablets Market Size, 2018-2029
6.6.4 Japan Fostamatinib Tablets Market Size, 2018-2029
6.6.5 South Korea Fostamatinib Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Fostamatinib Tablets Market Size, 2018-2029
6.6.7 India Fostamatinib Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fostamatinib Tablets Revenue, 2018-2029
6.7.2 By Country – South America Fostamatinib Tablets Sales, 2018-2029
6.7.3 Brazil Fostamatinib Tablets Market Size, 2018-2029
6.7.4 Argentina Fostamatinib Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fostamatinib Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fostamatinib Tablets Sales, 2018-2029
6.8.3 Turkey Fostamatinib Tablets Market Size, 2018-2029
6.8.4 Israel Fostamatinib Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Fostamatinib Tablets Market Size, 2018-2029
6.8.6 UAE Fostamatinib Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Rigel Pharmaceuticals
7.1.1 Rigel Pharmaceuticals Company Summary
7.1.2 Rigel Pharmaceuticals Business Overview
7.1.3 Rigel Pharmaceuticals Fostamatinib Tablets Major Product Offerings
7.1.4 Rigel Pharmaceuticals Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Rigel Pharmaceuticals Key News & Latest Developments
7.2 Kissei Pharmaceutical
7.2.1 Kissei Pharmaceutical Company Summary
7.2.2 Kissei Pharmaceutical Business Overview
7.2.3 Kissei Pharmaceutical Fostamatinib Tablets Major Product Offerings
7.2.4 Kissei Pharmaceutical Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Kissei Pharmaceutical Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Fostamatinib Tablets Major Product Offerings
7.3.4 Grifols Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 JW Pharmaceutical Corporation
7.4.1 JW Pharmaceutical Corporation Company Summary
7.4.2 JW Pharmaceutical Corporation Business Overview
7.4.3 JW Pharmaceutical Corporation Fostamatinib Tablets Major Product Offerings
7.4.4 JW Pharmaceutical Corporation Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.4.5 JW Pharmaceutical Corporation Key News & Latest Developments
7.5 Medison Pharma Canada
7.5.1 Medison Pharma Canada Company Summary
7.5.2 Medison Pharma Canada Business Overview
7.5.3 Medison Pharma Canada Fostamatinib Tablets Major Product Offerings
7.5.4 Medison Pharma Canada Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Medison Pharma Canada Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Fostamatinib Tablets Major Product Offerings
7.6.4 AstraZeneca Fostamatinib Tablets Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
8 Global Fostamatinib Tablets Production Capacity, Analysis
8.1 Global Fostamatinib Tablets Production Capacity, 2018-2029
8.2 Fostamatinib Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Fostamatinib Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fostamatinib Tablets Supply Chain Analysis
10.1 Fostamatinib Tablets Industry Value Chain
10.2 Fostamatinib Tablets Upstream Market
10.3 Fostamatinib Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fostamatinib Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Fostamatinib Tablets in Global Market
Table 2. Top Fostamatinib Tablets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fostamatinib Tablets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fostamatinib Tablets Revenue Share by Companies, 2018-2023
Table 5. Global Fostamatinib Tablets Sales by Companies, (K Units), 2018-2023
Table 6. Global Fostamatinib Tablets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fostamatinib Tablets Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Fostamatinib Tablets Product Type
Table 9. List of Global Tier 1 Fostamatinib Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fostamatinib Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Fostamatinib Tablets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fostamatinib Tablets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fostamatinib Tablets Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fostamatinib Tablets Sales (K Units), 2018-2023
Table 15. By Type - Global Fostamatinib Tablets Sales (K Units), 2024-2029
Table 16. By Application – Global Fostamatinib Tablets Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fostamatinib Tablets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fostamatinib Tablets Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fostamatinib Tablets Sales (K Units), 2018-2023
Table 20. By Application - Global Fostamatinib Tablets Sales (K Units), 2024-2029
Table 21. By Region – Global Fostamatinib Tablets Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fostamatinib Tablets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fostamatinib Tablets Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fostamatinib Tablets Sales (K Units), 2018-2023
Table 25. By Region - Global Fostamatinib Tablets Sales (K Units), 2024-2029
Table 26. By Country - North America Fostamatinib Tablets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fostamatinib Tablets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fostamatinib Tablets Sales, (K Units), 2018-2023
Table 29. By Country - North America Fostamatinib Tablets Sales, (K Units), 2024-2029
Table 30. By Country - Europe Fostamatinib Tablets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fostamatinib Tablets Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fostamatinib Tablets Sales, (K Units), 2018-2023
Table 33. By Country - Europe Fostamatinib Tablets Sales, (K Units), 2024-2029
Table 34. By Region - Asia Fostamatinib Tablets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fostamatinib Tablets Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fostamatinib Tablets Sales, (K Units), 2018-2023
Table 37. By Region - Asia Fostamatinib Tablets Sales, (K Units), 2024-2029
Table 38. By Country - South America Fostamatinib Tablets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fostamatinib Tablets Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fostamatinib Tablets Sales, (K Units), 2018-2023
Table 41. By Country - South America Fostamatinib Tablets Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Fostamatinib Tablets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fostamatinib Tablets Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fostamatinib Tablets Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Fostamatinib Tablets Sales, (K Units), 2024-2029
Table 46. Rigel Pharmaceuticals Company Summary
Table 47. Rigel Pharmaceuticals Fostamatinib Tablets Product Offerings
Table 48. Rigel Pharmaceuticals Fostamatinib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Rigel Pharmaceuticals Key News & Latest Developments
Table 50. Kissei Pharmaceutical Company Summary
Table 51. Kissei Pharmaceutical Fostamatinib Tablets Product Offerings
Table 52. Kissei Pharmaceutical Fostamatinib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Kissei Pharmaceutical Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Fostamatinib Tablets Product Offerings
Table 56. Grifols Fostamatinib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Grifols Key News & Latest Developments
Table 58. JW Pharmaceutical Corporation Company Summary
Table 59. JW Pharmaceutical Corporation Fostamatinib Tablets Product Offerings
Table 60. JW Pharmaceutical Corporation Fostamatinib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. JW Pharmaceutical Corporation Key News & Latest Developments
Table 62. Medison Pharma Canada Company Summary
Table 63. Medison Pharma Canada Fostamatinib Tablets Product Offerings
Table 64. Medison Pharma Canada Fostamatinib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Medison Pharma Canada Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Fostamatinib Tablets Product Offerings
Table 68. AstraZeneca Fostamatinib Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Fostamatinib Tablets Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Fostamatinib Tablets Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Fostamatinib Tablets Production by Region, 2018-2023 (K Units)
Table 73. Global Fostamatinib Tablets Production by Region, 2024-2029 (K Units)
Table 74. Fostamatinib Tablets Market Opportunities & Trends in Global Market
Table 75. Fostamatinib Tablets Market Drivers in Global Market
Table 76. Fostamatinib Tablets Market Restraints in Global Market
Table 77. Fostamatinib Tablets Raw Materials
Table 78. Fostamatinib Tablets Raw Materials Suppliers in Global Market
Table 79. Typical Fostamatinib Tablets Downstream
Table 80. Fostamatinib Tablets Downstream Clients in Global Market
Table 81. Fostamatinib Tablets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fostamatinib Tablets Segment by Type in 2022
Figure 2. Fostamatinib Tablets Segment by Application in 2022
Figure 3. Global Fostamatinib Tablets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fostamatinib Tablets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fostamatinib Tablets Revenue, 2018-2029 (US$, Mn)
Figure 7. Fostamatinib Tablets Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Fostamatinib Tablets Revenue in 2022
Figure 9. By Type - Global Fostamatinib Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 12. By Type - Global Fostamatinib Tablets Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Fostamatinib Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 16. By Application - Global Fostamatinib Tablets Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Fostamatinib Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fostamatinib Tablets Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 21. By Country - North America Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 23. US Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 28. Germany Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 29. France Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 37. China Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 41. India Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 44. Brazil Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fostamatinib Tablets Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fostamatinib Tablets Sales Market Share, 2018-2029
Figure 48. Turkey Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fostamatinib Tablets Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fostamatinib Tablets Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Fostamatinib Tablets by Region, 2022 VS 2029
Figure 54. Fostamatinib Tablets Industry Value Chain
Figure 55. Marketing Channels

※参考情報

フォスタマチニブ錠剤は、免疫関連の疾患に対する治療薬として開発された分子標的薬です。主に、自己免疫性疾患の一つである特発性血小板減少性紫斑病（ITP）の治療に用いられています。ここでは、フォスタマチニブの定義、特徴、使用される場面、関連技術について詳しく説明いたします。

フォスタマチニブは、リルマザトリプルという分子名で知られるもので、主にB細胞受容体シグナル伝達に関与するチロシンキナーゼであるSyk（Spleen Tyrosine Kinase）を阻害する作用を持っています。Sykは、多くの免疫細胞の機能に深く関与しており、B細胞やマクロファージの活性化、抗体産生、炎症反応などに重要な役割を果たしています。フォスタマチニブの作用により、これらの細胞の過剰な活性化を抑制することが可能となり、自己免疫性疾患において見られる病的な免疫反応を軽減します。

フォスタマチニブの特徴としては、経口投与が可能である点が挙げられます。これは患者にとっての服用の利便性を高める要因です。通常、治療は初期導入療法として一定期間内に用いられ、その後、患者の状態に応じて用量調整が行われます。効果の発現には数週間を要することが多いですが、多くの患者において著しい血小板数の改善が見られます。

フォスタマチニブは、特にITPの治療において劇的な効果を示すことがあります。ITPは自己免疫により血小板が減少する疾患で、出血や紫斑、場合によっては重篤な症状を引き起こすことがあります。従来の治療法としては、コルチコステロイドや免疫抑制剤などが使用されますが、これらの治療には副作用が伴うことが多く、十分な効果が得られない患者も少なくありません。このような背景から、フォスタマチニブの登場は新たな選択肢として注目されています。

フォスタマチニブの用途は主にITPに限られますが、研究の進展により他の自己免疫疾患や炎症性疾患に対する適応も考えられています。たとえば、関節リウマチや全身性エリテマトーデス（SLE）などにおいても、その可能性が探られています。これにより、フォスタマチニブは今後さらに多くの疾患に対する新たな治療法として位置づけられるかもしれません。

関連技術としては、フォスタマチニブの作用機序に関する研究が進められており、今後の新薬開発にとって重要な基礎になります。Syk阻害剤は、最近の研究で新たな治療ターゲットとして注目されており、他の関連分子に焦点を当てた新薬も開発されています。これにより、さらなる治療の選択肢が増えることを期待されているのです。

フォスタマチニブの副作用については、一般的には軽度から中等度のものが多く報告されています。最も一般的な副作用には、下痢、吐き気、腹痛、頭痛、発疹などがあります。また、血小板数の改善に伴い、特に出血リスクを心配することは少なくありませんが、これに関しては医療機関での経過観察が必要です。定期的な血液検査を通じて、血小板数のモニタリングが行われ、必要に応じて用量調整や治療方針の見直しが行われます。

以上のように、フォスタマチニブは自己免疫疾患に対する新たな治療薬としての位置づけを持ち、その特異な作用機序とともに多くの患者に希望をもたらす存在となっています。今後の研究や臨床試験を通じて、フォスタマチニブの適用拡大や副作用の軽減が図られ、より多くの患者に恩恵を与えることが期待されています。新たな治療法が次々と登場する現代において、フォスタマチニブはその一翼を担う重要な薬剤であり、今後もその活躍に注目が集まることでしょう。


★調査レポート[フォスタマチニブ錠剤のグローバル市場展望 2023年-2029年：100mg、150mg] (コード：MMG23DC14328)販売に関する免責事項を必ずご確認ください。
★調査レポート[フォスタマチニブ錠剤のグローバル市場展望 2023年-2029年：100mg、150mg]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • エノキサパリンナトリウムAPI・製剤の世界市場2023-2029：20mg/0.2mL、40mg/0.4mL、60mg/0.6mL、80mg/0.8mL、100mg/1mL、120mg/0.8mL、150mg/1mL、300mg/3mL
  • エルドステインカプセルの世界市場2023-2029：150mg、300mg

    • ◆H&Iグローバルリサーチのお客様（例）◆